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INTRODUCTION: Bilateral upper extremity ischemia is an unusual presentation of vascular disease. Aeti-
ologies include atherosclerosis as well as rheumatologic diseases. History and physical examination are
often, but not always, enough to distinguish between aetiologies and guide treatment.
PRESENTATION OF CASE: We present the case of a female patient with ﬁndings neither typical for
atherosclerotic or for rheumatologic disease who was ultimately found to have giant cell arteritis affect-
ing her bilateral upper extremities. She underwent bilateral upper extremity bypasses using saphenous
vein grafts.
DISCUSSION: This patient presented without symptoms and laboratory ﬁndings often seen with GCA,
however, biopsy revealed a deﬁnitive diagnosis. Treatment options for ischemia secondary to giant cell
arteritis are not well-documented in the literature.
CONCLUSION: Giant cell arteritis can present in atypical forms, and should remain on the differential
when atypical-appearing lesions are found, even in the absence of features usually associated with GCA.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The differential diagnosis for upper extremity ischemia is
broad and includes atherosclerotic disease, anatomic anomalies,
radiation-induced intimal hyperplasia, and large vessel vaculitides.
We present a patient who was ultimately determined to have giant
cell arteritis (GCA) causing bilateral upper extremity ischemia; her
atypical presentation illustrates the importance of a broad dif-
ferential for upper extremity claudication. She consented to the
publication of this manuscript.
2. Case report
A 69 year old woman presented to the ofﬁce with bilateral hand
pain, numbness, and tingling. She ﬁrst began to experience exer-
tional arm pain two months prior, and the pain had progressively
worsened. She denied any headaches, visual changes, jaw clau-
dication or shoulder or hip girdle stiffness. She had no history of
coronary or peripheral vascular disease.
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Her only medications were a lisinopril/hydrocholorthiazide
combination pill and a statin. She had never smoked andwas a veg-
etarian. Her only past surgery was a bilateral radical mastectomy
for breast cancer 25 years prior to presentation; this was accom-
panied by chemotherapy but not radiation. She had no history of
axillary lymph node dissection, radiation or trauma.
Onexamination, shewas a thin,well-appearingwoman. Shehad
non-palpable radial and ulnar pulses bilaterally and unobtainable
upper extremity blood pressures. She had no temporal artery ten-
derness or visible pulsation; there was no stiffness with range of
motion in her shoulders or hips.
The patient had previously seen her primary care provider and
brought a CT angiogram of the neck, which showed a left subcla-
vian artery irregularitywith a stenosis proximal towhere it crossed
the ﬁrst rib, a focal dilation in the proximal left axillary artery, and
severe axillary and brachial artery stenosis. She had an irregularity
of her right subclavian artery and an occluded right axillary artery
(Fig. 1). She was admitted to the hospital. Labs revealed a mildly
elevated ESR (40mm/h; normal 0–30mm/h), a normal hemoglobin
(12.3 g/dL; normal 12.0–16.0 g/dL) and were otherwise unremark-
able.
An angiogram showed a 3–4 cm focal occlusion of her right
axillo-brachial artery with reconstitution of her brachial artery
(Fig. 2). The left subclavian arterywas occluded just past the takeoff
http://dx.doi.org/10.1016/j.ijscr.2015.06.009
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Fig. 1. CT angiogram showing (A) irregularity of the left subclavian and segmental stenoses of the left axillary artery and (B) focal occlusion of the right axillary artery.
of the vertebral. Her left axillary artery reconstituted inferior to the
clavicle.
Rheumatology was consulted and recommended biopsy of
either the bypass site or temporal artery. A hsCRP was found to
be markedly elevated at 118.4mg/L (normal range <7.4mg/L). Her
lipids were within normal range.
She underwent a left common carotid to left brachial bypass
using cephalic vein. A segment of the carotid artery was sent for
pathology and showed connective tissue with myxoid changes.
She subsequently underwent a right axillary to brachial artery
bypass with reversed cephalic vein. The bilateral temporal arteries
were biopsied, and pathology showed chronic inﬂammation with
rare giant cells in the media and adventitia, as well as focal dis-
ruption of the elastic lamina (Fig. 3). The diagnosis of giant cell
arteritis was made, and she was started on prednisone 60mg daily
with a plan to taper over the next eighteen–twenty-four months.
Additional imaging of abdominal vasculature revealed critical right
renal artery stenosis. Her lisinopril was discontinued. She was dis-
charged home on post-operative day 5 after the second operation.
In follow-up in clinic, she felt well with complete resolution of her
symptoms.
3. Discussion
Giant cell arteritis is found in 7–20 people per 100,000 per
year, often in those older than 50 years and of Northern Euro-
pean descent [1]. Its pathogenesis is thought to be a combination
of environmental exposures and genetic polymorphisms. CD4 T
cells migrate to the vasa vasorum, stimulating inﬂammation and
attracting macrophages, leading to the formation of multinucle-
ated giant cells and intimal expansion [1]. The presentation may
be acute or insidious, and includes jaw claudication, as well as
constitutional symptoms such as weight loss, fever, and fatigue.
Symptoms often include ﬁndings of polymyalgia rheumatica, such
as shoulder and hip girdle stiffness. Lab ﬁndings may include an
ESR>80, anelevatedCRP, leucocytosis, anemia, and thrombocytosis.
Thepresence of 3 ormoreAmericanCollege of RheumatologyCrite-
ria (development of symptoms at the age of 50 or older, headache,
temporal artery tenderness or decreased palpation, ESR >50, and
biopsy with giant cells) is greater than 90% sensitive and speciﬁc
[2] for a diagnosis of giant cell arteritis. This patient had none of
the typical ﬁndings, and did not meet ACR criteria for giant cell
arteritis.
Fig. 2. Digital subtraction angiogram showing (A) focal occlusion of the right axillary artery with reconstitution of the brachial artery and (B) severely stenotic left subclavian
and axillary arteries.
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Fig. 3. Temporal artery biopsy results showing (A) giant cells (black arrows) on H&E stained section, as well as (B) disruption of the internal elastic lamina (black arrows) on
a Verhoeff Van Giesen stained section.
Evidence of upper extremity involvement is found in 10–30%
of patients [3]. Patients with upper extremity involvement are
typically female, younger, and less likely to have headaches, jaw
claudication, and anterior ischemic neuropathy [4]. Despite the
prevalence of upper extremity involvement in GCA, only 1–2% of
patients present with arm claudication or ischemia [5]. Tempo-
rary artery biopsy is often negative in patients with large vessel
manifestations of GCA [6].
The medical treatment of GCA is well-established; patients are
treated with steroids as well as medications to prevent their side
effects [1]. Surgical options are less well-deﬁned. There are case
reports and small series describing angioplasty for lesions seen in
temporal arteritis; there have been conﬂicting results, with some
series reporting success and resolution of symptoms when stent-
ing or angioplasty is used in conjunction with steroids [7–10] and
others reporting as many as 50% of patients needing additional
procedures [11]. Additionally, one case series on endovascular
treatments reports dissection ﬂaps complicating 16 of 40 arter-
ies angioplastied [11]. The data is similarly scant for results with
open bypass, again a subject of several case reports [5,9,12–17].
The type of bypass conduit is not always detailed, particularly in
those studies published in the rheumatologic literature. Data is
therefore, limited to make meaningful conclusions regarding the
optimal conduit.
In this patient, we chose to perform a bypass rather than stent
the lesions. She had long stenoses on both sides, making endovas-
cular techniques suboptimal. Stenting would also have involved
stenting across joints, placing the stents under repetitive stress and
possible risk of fracture. Abypasswas therefore selected; the choice
between prosthetic and vein was made due to her relatively young
age, the availability of suitable cephalic vein bilaterally, and the
superiority of vein as a conduit in lower extremity bypass.
In the existing literature, steroids are often used in conjunction
with surgery [13,14,18]. Here, a steroid taper was started after the
second operation because the diagnosis was not deﬁnitive until
after her second surgery. In some cases, steroids obviate the need
for surgery [9,11], but there is not enough literature to determine
the best timing of steroid administration.
Renal artery stenosis was found in this patient upon imaging of
the rest of her vasculature. Making the diagnosis is important in
order to prompt the administration of steroids, but also to initiate
evaluation of the rest of the vasculature. The involvement of the
aorta and other vessels is frequent in patients with GCA [4]; they
have twice the risk of the normal population of having an aortic
aneurysm [19].
Thispatienthadanunusualpresentationof inﬂammatoryarteri-
tis: she had none of the ACR criteria symptoms and a near-normal
ESR. Her arteriogram showed long segment involvementwith focal
stenosis and dilations, typical of giant cell arteritis. Temporal artery
biopsy provided the deﬁnitive diagnosis in this patient and should
be consideredwhen the appearance of the arterial lesion is unusual,
even in the absence of typical GCA features.
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